← Back to Search

Symptomatic for Gastroesophageal Reflux Disease

N/A
Waitlist Available
Led By Rena Yadlapati, M.D.
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4
Awards & highlights
No Placebo-Only Group

Summary

This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.

Eligible Conditions
  • Gastroesophageal Reflux Disease
  • Laryngopharyngeal Reflux
  • Acid Reflux

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient-reported Symptom Response to Treatment Measured by the Reflux Symptom Index (RSI) Score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SymptomaticExperimental Treatment1 Intervention
This study examines the efficacy of the upper esophageal sphincter assist device as an adjunct to Proton-pump inhibitors (PPI) therapy in symptomatic subjects. (Reflux Band® Upper Esophageal Sphincter (UES) Assist Device)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reflux Band® Upper Esophageal Sphincter (UES) Assist Device
2018
N/A
~50

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,181 Previous Clinical Trials
1,575,676 Total Patients Enrolled
Rena Yadlapati, M.D.Principal Investigator - University of California, San Diego
University of California, San Diego
~6 spots leftby Nov 2025